Patrick Dillon, MD
Medical Oncology · Charlottesville, VANPI 1952502718
Payments from drug & device makers
Across 355 payments — averaging $7256.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$827K
- Seagen Inc.$584K
- AstraZeneca$304K
- Radius Health, Inc.$236K
- Tesaro, Inc.$216K
- Pfizer$189K
- plus $219K from 9 others
Across 6 payments — averaging $248.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Radius Health, Inc.$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 42 | $827,170 |
| Seagen Inc. | 80 | $584,400 |
| AstraZeneca | 11 | $303,963 |
| Radius Health, Inc. | 20 | $236,048 |
| Tesaro, Inc. | 14 | $216,451 |
| Pfizer | 26 | $189,314 |
| Stemline Therapeutics Inc. | 128 | $107,026 |
| Daiichi Sankyo Inc. | 7 | $62,064 |
| GSK | 5 | $15,437 |
| AbbVie | 6 | $13,127 |
| Genentech, Inc. | 3 | $8,623 |
| Novartis | 10 | $6,862 |
| Imclone Systems, LLC | 1 | $5,560 |
| Lilly USA, LLC | 1 | $79 |
| Gilead | 1 | $12 |
How this compares
$2,576,134 in reported general payments places this provider in the 90th percentile of 95 medical oncology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Charlottesville
- Ryan GentzlerCharlottesville$5.6M
- Robert DreicerCharlottesville$5.4M
- Matthew ReilleyCharlottesville$3.8M
- Varinder KaurCharlottesville$2.4M
- Richard HallCharlottesville$1.7M
- Enrica MarchiCharlottesville$1.2M
- Paul KunkCharlottesville$669K
- Ludimila CavalcanteCharlottesville$525K
- Tri leCharlottesville$323K
- Trish MillardCharlottesville$244K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.